Evaluation of Ambulatory ECG Telemetry for the Early Detection of Atrial Fibrillation During Hospital Assessment of Cerebral Infarction

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03992157

Acronym

TELEMETRIE

Enrollment

Registered

2019-06-20

Start date

2018-12-27

Completion date

2019-07-03

Last updated

2020-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarction

Keywords

stroke, ECG, telemetry, atrial fibrillation

Brief summary

The aim of the study is to show that an ambulatory ECG telemetry monitoring of some patients hospitalized for cerebral infarction increases the frequency of the diagnosis of atrial fibrillation, cause of their stroke, and reinforces the protection against recurrences.

Interventions

DEVICEECG telemetry

ECG telemetry (holter ECG) is a portable case - attached to the belt or around the neck - connected to 6 electrodes placed on the skin next to the heart. They are worn by patients during their stay in hospital

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients over 18 years old * Diagnosis of transient ischemic or cerebral accident * Absence of etiological orientation after the initial assessment (including at least cerebral MRI, angiography of the supra aortic trunks by CT or MRI, echocardiography with search for patent foramen ovale, standard biology) * Affiliated to a social security system. * Having given no opposition to participation in research

Exclusion criteria

* AF known or diagnosed during stay in USINV

Design outcomes

Primary

Measure	Time frame	Description
Diagnostic impact of outpatient ECG telemetry	6 months	Percentage of patients hospitalized for cerebral infarction and with a diagnosis of atrial fibrillation allowed by the use of ambulatory ECG telemetry.

Secondary

Measure	Time frame	Description
Identification of prognostic factors to identify de novo atrial fibrillation	6 months	Retrospective evaluation of prognostic criteria (clinical data, biomarkers, abdominal MRI) in patients with a diagnosis of AF
Evaluate the therapeutic impact (prescription anticoagulant) at the end of hospitalisation	6 months	Percentage of patients on anticoagulation at the end of hospitalisation
Evaluate the benefit on the recurrence rate of cerebral infarction after the exit of the service	3 months	Percentage of IC recurrence in the department and within 3 months of the IC diagnosis

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026